tiprankstipranks
Trending News
More News >
Puma Biotechnology (PBYI)
NASDAQ:PBYI
US Market

Puma Biotechnology (PBYI) Stock Investors

Compare
631 Followers
Based on 795,508 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PBYI
On average, investors allocate 0.00% of their portfolios to PBYI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 795,508 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PBYI

4.4%
Last 7
Days
6.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PBYI, out of 795,508 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PBYI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.68%
$3.00
Based on the activity of investors who made their portfolios public
The table shows changes in PBYI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PBYI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
3.75%
-1.71%
-2.58%
2.50B
Healthcare
JD
4.90%
-0.92%
+0.31%
58.66B
Consumer Cyclical
First Solar
4.03%
+0.49%
+3.43%
13.50B
Technology
Block
3.63%
+0.48%
+3.51%
33.41B
Technology
Bristol-Myers Squibb
3.33%
-0.87%
-0.59%
103.18B
Healthcare
Intuitive Surgical
3.62%
-0.31%
+2.70%
176.84B
Healthcare
Devon Energy
3.80%
-1.14%
-0.90%
18.32B
Energy
Abbott Labs
3.50%
-0.79%
-0.13%
220.05B
Healthcare
CVS Health
4.46%
+1.23%
+0.48%
87.75B
Healthcare
Nio
8.79%
-1.49%
-1.52%
6.97B
Consumer Cyclical
Based on the activity of 795,508 active portfolios
Open your Smart Portfolio

PBYI Investor Analysis

PBYI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.0%
of PBYI holders
are under 35
Average Segment Performance
Average P/E Ratio15.76
Beta5.52
Dividend Yield4.35%
PBYI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
44.0%
of PBYI holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.88
Beta14.39
Dividend Yield3.83%
PBYI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of PBYI holders
are over 55
Average Segment Performance
Average P/E Ratio11.99
Beta7.82
Dividend Yield4.14%
Overview of age group and performance of PBYI stock investors
See who invests in PBYI according to age group and performance.

FAQ

How many retail Investors hold PBYI?
<0.1% of TipRanks' retail investors hold PBYI in their portfolios.
    What is PBYI Investor Sentiment?
    PBYI’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PBYI in the last 7 days?
      ▼ 4.4% of TipRanks' retail investors changed their holding of PBYI in the last 7 days.
        What percentage of retail investors changed their holding of PBYI in the last 30 days?
        ▼ 6.6% of TipRanks' retail investors changed their holding of PBYI in the last 30 days.
          What is the average age of retail investors who hold PBYI?
          The average age of PBYI Holders is over 55.
            What other stocks have PBYI investors also bought?
            PBYI Investors also bought VKTX, JD, FSLR, XYZ, BMY, ISRG, DVN, ABT, CVS, NIO.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              CORCencora
              ANGOAngioDynamics
              BIIBBiogen
              BMRNBioMarin Pharmaceutical
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis